Search research articles
Contact Us
Filters
Showing results (61-70 of 164) with videos related to
Page
of 17
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
scExploreR: a flexible platform for democratized analysis of multimodal single-cell data by non-programmers
William M Showers, Jairav Desai, Stephanie R Gipson, et al.
Blood
|
February 3, 2005
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
Monica L Guzman, Randall M Rossi, Lilliana Karnischky, et al.
Bioorganic & Medicinal Chemistry
|
January 5, 2017
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia
Zaineb A F Albayati, Venumadhav Janganati, Zheng Chen, et al.
Plos One
|
January 24, 2014
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells
Shuqian Liu, Sumitra Miriyala, Mignon A Keaton, et al.
JMIR Cancer
|
August 21, 2024
Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study
Nazmul Islam, Jamie S Reuben, Justin Dale, et al.
European Journal of Medicinal Chemistry
|
August 20, 2018
MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells
Venumadhav Janganati, Jessica Ponder, Meenakshisundaram Balasubramaniam, et al.
Metabolites
|
April 28, 2023
Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2
Rachel Culp-Hill, Brett M Stevens, Courtney L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
Saman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2002
Preferential induction of apoptosis for primary human leukemic stem cells
Monica L Guzman, Carol F Swiderski, Dianna S Howard, et al.
Nature Communications
|
September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
Brett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 164) with videos related to
Sort By:
Page
of 17
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
scExploreR: a flexible platform for democratized analysis of multimodal single-cell data by non-programmers
William M Showers, Jairav Desai, Stephanie R Gipson, et al.
Blood
|
February 3, 2005
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
Monica L Guzman, Randall M Rossi, Lilliana Karnischky, et al.
Bioorganic & Medicinal Chemistry
|
January 5, 2017
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia
Zaineb A F Albayati, Venumadhav Janganati, Zheng Chen, et al.
Plos One
|
January 24, 2014
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells
Shuqian Liu, Sumitra Miriyala, Mignon A Keaton, et al.
JMIR Cancer
|
August 21, 2024
Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study
Nazmul Islam, Jamie S Reuben, Justin Dale, et al.
European Journal of Medicinal Chemistry
|
August 20, 2018
MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells
Venumadhav Janganati, Jessica Ponder, Meenakshisundaram Balasubramaniam, et al.
Metabolites
|
April 28, 2023
Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2
Rachel Culp-Hill, Brett M Stevens, Courtney L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
Saman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2002
Preferential induction of apoptosis for primary human leukemic stem cells
Monica L Guzman, Carol F Swiderski, Dianna S Howard, et al.
Nature Communications
|
September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
Brett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Page
of 17